- Home
- ELVN vs BRAI Comparison
ELVN vs BRAI Comparison
Compare ELVN & BRAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$27.41
Company Overview
Basic Information| Metric | ELVN | BRAI |
|---|---|---|
| Founded | 2016 | N/A |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.6B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | ELVN | BRAI |
|---|---|---|
| Price | $27.41 | $21.49 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $41.00 | N/A |
| AVG Volume (30 Days) | ★ 647.0K | 81.4K |
| Earning Date | 06-05-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 3.17 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $40.06 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.30 | $12.56 |
| 52 Week High | $30.98 | $32.32 |
Technical Indicators
Market Signals| Indicator | ELVN | BRAI |
|---|---|---|
| Relative Strength Index (RSI) | 46.09 | 47.31 |
| Support Level | $18.89 | $12.83 |
| Resistance Level | $29.63 | $25.00 |
| Average True Range (ATR) | 1.61 | 6.55 |
| MACD | -0.34 | -0.20 |
| Stochastic Oscillator | 2.18 | 39.98 |
Price Performance
Historical Comparison ELVN
BRAI
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.